rfC included in the new draft 5.1.10 by the European Pharmacopeia
News from the European Pharmacopoeia:
The new draft of chapter 5.1.10 published in Pharmeuropa 26.4 by the European Pharmacopoeia last Friday includes Recombinant Factor C (rFC) methods as well as the EndoLISA technology.
The text for comments can be obtained here >>
Deadline for comments is 31.12.2014.